Breast Cancer Survival Model for Invasive Micropapillary Carcinoma, 2010-2018

A retrospective study of 1,150 patients from the SEER database (2010–2018) and an external validation cohort of 199 patients from Nanjing Drum Tower Hospital. The dataset likely contains clinical and pathological features used to develop a risk stratification model for survival outcomes in invasive micropapillary carcinoma of the breast. It was authored by Fang Yang and last updated on 2026-06-04.

Use Cases

• Predicting overall survival based on clinical features like marital status, tumor size, and radiotherapy history.
• Stratifying patients into high- and low-risk groups for chemotherapy benefit assessment.
• Validating prognostic models for invasive micropapillary carcinoma using external clinical cohorts.

Strengths

• Includes 1,150 patient records from the SEER database.
• Validated with an external cohort of 199 patients from a hospital.
• Model results include hazard ratios and confidence intervals for survival outcomes.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the primary dataset is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to the SEER database and a single external hospital.

Provenance

Source

SEER database and Nanjing Drum Tower Hospital.

Collection Method

Retrospective study using propensity score matching.

Time Range

2010-2018

Freshness

Last updated 2026-06-04 04:30:30

Geography

United States (SEER) and China (Nanjing).